Home/Filings/4/0001209191-21-064934
4//SEC Filing

Luo Allison 4

Accession 0001209191-21-064934

CIK 0001718852other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 9:06 PM ET

Size

5.6 KB

Accession

0001209191-21-064934

Insider Transaction Report

Form 4
Period: 2021-11-14
Luo Allison
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-11-14+113,677113,677 total
    Exercise: $36.32Exp: 2031-11-13Common Stock (113,677 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option will vest on November 14, 2022, and 1/48th of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's continued service with the Issuer through each vest date.

Issuer

Prometheus Biosciences, Inc.

CIK 0001718852

Entity typeother

Related Parties

1
  • filerCIK 0001849225

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 9:06 PM ET
Size
5.6 KB